Most of the prepared compounds evidenced interesting antiproliferative activity against FAK-overexpressing PC cells (namely, AsPC-1, BxPC-3, Panc-1) and also against two drug-resistant cancer cell lines (breast cancer MCF-7 cells and lung cancer H1975 cells) at concentrations lower than 7 μM. The gene discussed is PTK2; the disease is lung carcinoma.